Morgan Stanley Tiziana Life Sciences LTD Call Options Transaction History
Morgan Stanley
- $1.36 Trillion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding TLSA
# of Institutions
36Shares Held
3.1MCall Options Held
24KPut Options Held
800-
Dauntless Investment Group, LLC Commerce Township, MI1.74MShares$3.74 Million2.2% of portfolio
-
Jane Street Group, LLC New York, NY168KShares$360,2150.0% of portfolio
-
Omers Administration Corp Toronto, A6145KShares$311,5350.0% of portfolio
-
Hsbc Holdings PLC London, X0105KShares$226,5340.0% of portfolio
-
Zhang Financial LLC89.8KShares$192,9840.01% of portfolio
About Tiziana Life Sciences Ltd
- Ticker TLSA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,273,000
- Market Cap $220M
- Description
- Tiziana Life Sciences Ltd, a biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology. The company's lead product candidate in immunology is Foralumab (TZLS-401), a human anti-CD3 monoclonal antibody (mAb) for the treatment of Crohn's, graft versus host, ulcerative colitis, m...